SEC Form 4
Helix Acquisition Corp. III (HLXC) insider trading
In the 12 months to Nov 19, 2026, one HLXC insider reported open-market purchases of $8.0M across 1 filing; no open-market sales were filed.
Latest filing · Last 12 months · Source: SEC EDGAR · How we count
- Open-market sales
- $0
- 0 filings · 0 insiders
- Open-market purchases
- $8.0M
- 1 filing · Bihua Chen, Chairperson and CEO
Who traded HLXC, and when
- Purchase
HLXC daily close from Jan 23, 2026 to Nov 18, 2026, between $10.15 and $11.00, last $10.31. 0 sale and 1 purchase filings by 1 insider, marked at their filing dates. Bihua Chen, Chairperson and CEO: bought $8.0M across 1 filing, first filed Jan 28, 2026, last Jan 28, 2026.
Largest mark · tap a row for others
Bihua Chen · Chairperson and CEO
Purchase $8,000,000
800,000 shares
Filed Jan 28, 2026 · traded Jan 26
Close on filing date $10.26
Bihua Chen · Chairperson and CEO
Chairperson and CEO
$8.0M boughtOpen-market trades
1 filing in the last 12 months| Insider | Role | Sold | Bought | Filings | Pre-arranged (10b5-1) | Last filed |
|---|---|---|---|---|---|---|
| Bihua Chen | Chairperson and CEO | — | $8.0M | 1 | — |
| Filed | Insider | Type | Shares | Value | Held after | Source |
|---|---|---|---|---|---|---|
traded | Bihua Chen Chairperson and CEO | Purchase | 800,000 ordinary shares | $8.0M | 800,000 |
Shares are as filed (ordinary shares or ADS); values are as converted to US$ in the filing.
GET /stocks/filings/vX/form-4?tickers=HLXC&filing_date.gte=2025-11-19&sort=filing_date.desc&limit=500{
"status": "OK",
"results": [
{
"tickers": [
"HLXC"
],
"issuer_cik": "0002099656",
"owner_cik": "0002105798",
"accession_number": "0001213900-26-009021",
"form_type": "4/A",
"filing_date": "2026-01-28",
"period_of_report": "2026-01-26",
"issuer_name": "Helix Acquisition Corp. III",
"issuer_trading_symbol": "HLXC",
"owner_name": "Helix Holdings III LLC",
"is_director": false,
"is_officer": false,
"is_ten_percent_owner": true,
"is_other": true,
"security_type": "non_derivative",
"record_type": "transaction",
"security_title": "Class A Ordinary Shares",
"transaction_timeliness": "O",
"aff_10b5_one": false,
"transaction_date": "2026-01-26",
"transaction_code": "P",
"equity_swap_involved": false,
"transaction_shares": 800000,
"transaction_price_per_share": 10,
"transaction_acquired_disposed": "A",
"shares_owned_following_transaction": 800000,
"transaction_value": 8000000,
"date_of_original_submission": "2026-01-26",
"not_subject_to_section_16": false,
"direct_or_indirect": "I",
"nature_of_ownership": "See Footnote",
"footnotes": [
{
"id": "F2",
"description": "This form amends a Form 4 previously filed for the Reporting Person on January 26, 2026 to correct the number of shares that should have been reported on such date, which now includes shares purchased by Cormorant Global Healthcare Master Fund, LP in the Issuer's initial public offering, as described in further detail in the Issuer's registration statement on Form S-1 (File No. 333-291933) (\"Registration Statement\")."
},
{
"id": "F3",
"description": "Cormorant Global Healthcare Master Fund, LP is the record holder of such securities. Ms. Chen is the managing member of Cormorant Global Healthcare Master Fund, LP and has voting and investment discretion with respect to the ordinary shares of record held thereby. Ms. Chen disclaims any beneficial ownership of the securities held by Cormorant Global Healthcare Master Fund, LP other than to the extent of any pecuniary interest she may have therein, directly or indirectly."
}
],
"remarks": "Helix Holdings III LLC may be deemed a director by deputization by virtue of its representation on the board of directors of the Issuer. See Exhibit 99.1 - Joint Filer Information, which is incorporated herein by reference and describes in further detail the relationships of the Reporting Persons to the Issuer."
},
{
"tickers": [
"HLXC"
],
"issuer_cik": "0002099656",
"owner_cik": "0001599214",
"accession_number": "0001213900-26-009021",
"form_type": "4/A",
"filing_date": "2026-01-28",
"period_of_report": "2026-01-26",
"issuer_name": "Helix Acquisition Corp. III",
"issuer_trading_symbol": "HLXC",
"owner_name": "Chen Bihua",
"is_director": true,
"is_officer": true,
"is_ten_percent_owner": true,
"is_other": false,
"officer_title": "Chairperson and CEO",
"security_type": "non_derivative",
"record_type": "transaction",
"security_title": "Class A Ordinary Shares",
"transaction_timeliness": "O",
"aff_10b5_one": false,
"transaction_date": "2026-01-26",
"transaction_code": "P",
"equity_swap_involved": false,
"transaction_shares": 800000,
"transaction_price_per_share": 10,
"transaction_acquired_disposed": "A",
"shares_owned_following_transaction": 800000,
"transaction_value": 8000000,
"date_of_original_submission": "2026-01-26",
"not_subject_to_section_16": false,
"direct_or_indirect": "I",
"nature_of_ownership": "See Footnote",
"footnotes": [
{
"id": "F2",
"description": "This form amends a Form 4 previously filed for the Reporting Person on January 26, 2026 to correct the number of shares that should have been reported on such date, which now includes shares purchased by Cormorant Global Healthcare Master Fund, LP in the Issuer's initial public offering, as described in further detail in the Issuer's registration statement on Form S-1 (File No. 333-291933) (\"Registration Statement\")."
},
{
"id": "F3",
"description": "Cormorant Global Healthcare Master Fund, LP is the record holder of such securities. Ms. Chen is the managing member of Cormorant Global Healthcare Master Fund, LP and has voting and investment discretion with respect to the ordinary shares of record held thereby. Ms. Chen disclaims any beneficial ownership of the securities held by Cormorant Global Healthcare Master Fund, LP other than to the extent of any pecuniary interest she may have therein, directly or indirectly."
}
],
"remarks": "Helix Holdings III LLC may be deemed a director by deputization by virtue of its representation on the board of directors of the Issuer. See Exhibit 99.1 - Joint Filer Information, which is incorporated herein by reference and describes in further detail the relationships of the Reporting Persons to the Issuer."
}
]
}
// trimmed to 2 resultsThe response includes every Form 4 record; this page keeps open-market purchases and sales on common stock and removes duplicate joint-filer rows.
Other insider activity (not market trades) · 1 record
- Grants and awards1 record
Reported on Form 4 but not purchases or sales in the market, so not counted in the totals above.
How to read this page
- Open-market purchase or sale
- A buy or sell of the company's stock at market price. Grants, option exercises, shares withheld for tax, gifts and employee stock plan purchases are listed separately and not counted.
- Filing date
- Insiders have two business days to report a trade. Totals and the chart use the filing date, when the trade became public.
- Counted once
- When several owners (a fund and its partners, say) report the same trade, it's counted once. Corrected filings replace the originals.
Frequently asked questions
Has Helix Acquisition Corp. III's CEO sold stock?
No. Bihua Chen (CEO) made no open-market sales filed as CEO in the last 12 months.
How current is HLXC’s insider data?
These are HLXC Form 4 filings from the last year, refreshed daily. The Massive Form 4 API has the full, continuously updated record.
What counts as an open-market buy or sell?
Only purchases and sales at the market price. Option exercises, grants, gifts, and shares withheld for taxes are reported on Form 4 but are left out of the buy and sell totals.
Build with AI
Track HLXC insider trades with your agent
This page joins two Massive endpoints: Form 4 filings and daily prices. Ask an agent to watch for new filings:
Using the Massive API (massive.com/docs/llms.txt), check Form 4 filings for HLXC every day with transaction_code=P and tell me when an insider files an open-market purchase, with their role, shares, price and the filing link.
Nothing on this page is investment advice. All data and content is provided for informational purposes under our Terms of Service.